• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区慢性便秘:澳大利亚成年人全国调查。

Chronic Constipation in the Community: A National Survey of Australian Adults.

机构信息

Barry L. Werth, PhD, Sydney Nursing School, University of Sydney, New South Wales, Australia.

Murray J. Fisher, PhD, Sydney Nursing School, University of Sydney, New South Wales, Australia.

出版信息

J Wound Ostomy Continence Nurs. 2020 May/Jun;47(3):259-264. doi: 10.1097/WON.0000000000000632.

DOI:10.1097/WON.0000000000000632
PMID:32332586
Abstract

PURPOSE

The aim of this study was to determine the prevalence of chronic constipation and identify factors associated with chronic constipation in community-dwelling adults.

DESIGN

Cross-sectional study.

METHODS

The target population was community-dwelling Australian adults; 1978 participants completed an online questionnaire exploring symptoms, management, and factors potentially associated with constipation. Chronic constipation was identified using Rome III criteria. Multivariate logistic regression model was used to identify factors associated with chronic constipation.

RESULTS

The prevalence of chronic constipation was 23.9%. Factors significantly associated with chronic constipation in the multivariate model were female gender (odds ratio [OR] = 1.42, 95% confidence interval [CI], 1.12-1.81), current employment (OR = 1.45, 95% CI, 1.11-1.88), regular smoking (OR = 1.60, 95% CI, 1.19-2.14), poor self-rated health (OR = 2.57, 95% CI, 1.28-5.19), thyroid disease (OR = 1.77, 95% CI, 1.21-2.79), depression (OR = 1.49, 95% CI, 1.08-2.06), hemorrhoids (OR = 2.98, 95% CI, 1.84-4.83), irritable bowel syndrome (OR = 2.45, 95% CI, 1.73-3.46), and use of anti-inflammatory/antirheumatic medications (OR = 2.06, 95% CI, 1.15-3.68). In contrast to these factors, use of medications acting on the renin-angiotensin system was associated with a reduced likelihood of chronic constipation (OR = 0.47, 95% CI, 0.24-0.91).

CONCLUSIONS

Chronic constipation is prevalent among community-dwelling adults. Various factors associated with chronic constipation have been identified, and knowledge of these factors may help health care professionals recognize individuals who are at high risk of chronic constipation.

摘要

目的

本研究旨在确定社区居民成年人慢性便秘的患病率,并确定与慢性便秘相关的因素。

设计

横断面研究。

方法

研究对象为社区居民的澳大利亚成年人;1978 名参与者完成了一份在线问卷,内容涉及症状、管理和可能与便秘相关的因素。使用罗马 III 标准确定慢性便秘。使用多变量逻辑回归模型确定与慢性便秘相关的因素。

结果

慢性便秘的患病率为 23.9%。多变量模型中与慢性便秘显著相关的因素为女性(比值比 [OR] = 1.42,95%置信区间 [CI],1.12-1.81)、当前就业(OR = 1.45,95%CI,1.11-1.88)、规律吸烟(OR = 1.60,95%CI,1.19-2.14)、自我健康评估差(OR = 2.57,95%CI,1.28-5.19)、甲状腺疾病(OR = 1.77,95%CI,1.21-2.79)、抑郁症(OR = 1.49,95%CI,1.08-2.06)、痔疮(OR = 2.98,95%CI,1.84-4.83)、肠易激综合征(OR = 2.45,95%CI,1.73-3.46)和使用抗炎/抗风湿药物(OR = 2.06,95%CI,1.15-3.68)。与这些因素相反,使用作用于肾素-血管紧张素系统的药物与慢性便秘的可能性降低相关(OR = 0.47,95%CI,0.24-0.91)。

结论

慢性便秘在社区居民成年人中较为普遍。确定了与慢性便秘相关的各种因素,了解这些因素可能有助于医疗保健专业人员识别患有慢性便秘的高风险人群。

相似文献

1
Chronic Constipation in the Community: A National Survey of Australian Adults.社区慢性便秘:澳大利亚成年人全国调查。
J Wound Ostomy Continence Nurs. 2020 May/Jun;47(3):259-264. doi: 10.1097/WON.0000000000000632.
2
Defining constipation to estimate its prevalence in the community: results from a national survey.定义便秘以便估计其在社区中的流行率:一项全国性调查的结果。
BMC Gastroenterol. 2019 May 21;19(1):75. doi: 10.1186/s12876-019-0994-0.
3
Prevalence of constipation: agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported definition in a population-based survey in Spain.便秘的患病率:西班牙一项基于人群的调查中几种标准之间的一致性以及对限定症状和自我报告定义的诊断准确性评估
Am J Epidemiol. 2004 Mar 1;159(5):520-6. doi: 10.1093/aje/kwh072.
4
Shared Risk Factors for Constipation, Fecal Incontinence, and Combined Symptoms in Older U.S. Adults.美国老年成年人便秘、大便失禁及合并症状的共同风险因素。
J Am Geriatr Soc. 2016 Nov;64(11):e183-e188. doi: 10.1111/jgs.14521. Epub 2016 Oct 26.
5
Laxative Use and Self-Reported Constipation in a Community-Dwelling Elderly Population: A Community-Based Survey From Australia.社区居住老年人群中泻药的使用与自我报告的便秘情况:一项来自澳大利亚的社区调查
Gastroenterol Nurs. 2017 Mar/Apr;40(2):134-141. doi: 10.1097/SGA.0000000000000144.
6
The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.根据罗马III诊断标准评估帕金森病患者便秘和肠易激综合征的患病率
J Parkinsons Dis. 2017;7(2):353-357. doi: 10.3233/JPD-160982.
7
Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.美国、加拿大和英国成年人中罗马 IV 功能性肠病的流行情况。
Gastroenterology. 2020 Apr;158(5):1262-1273.e3. doi: 10.1053/j.gastro.2019.12.021. Epub 2020 Jan 7.
8
Factors associated with impaired quality of life in French patients with chronic idiopathic constipation: a cross-sectional study.法国慢性特发性便秘患者生活质量受损的相关因素:一项横断面研究。
Eur J Gastroenterol Hepatol. 2016 May;28(5):525-31. doi: 10.1097/MEG.0000000000000595.
9
Constipation in adults with neurofibromatosis type 1.成人 1 型神经纤维瘤病患者的便秘。
Orphanet J Rare Dis. 2017 Aug 16;12(1):139. doi: 10.1186/s13023-017-0691-4.
10
Constipation in community-dwelling elders: prevalence and associated factors.社区居住老年人便秘:患病率及相关因素。
J Wound Ostomy Continence Nurs. 2012 Nov-Dec;39(6):640-5. doi: 10.1097/WON.0b013e31826a4b70.

引用本文的文献

1
Prevalence and associated factors of chronic constipation among Japanese university students.日本大学生慢性便秘的患病率及相关因素。
Front Public Health. 2024 Jan 16;12:1258020. doi: 10.3389/fpubh.2024.1258020. eCollection 2024.
2
GI factors, potential to predict prostate motion during radiotherapy; a scoping review.胃肠道因素:预测放疗期间前列腺运动的潜力;一项范围综述
Clin Transl Radiat Oncol. 2023 Feb 26;40:100604. doi: 10.1016/j.ctro.2023.100604. eCollection 2023 May.
3
Effects of P9 Probiotics on Defecation and Quality of Life of Individuals with Chronic Constipation: Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
P9益生菌对慢性便秘患者排便及生活质量的影响:一项随机、双盲、安慰剂对照临床试验方案
Evid Based Complement Alternat Med. 2022 Jun 13;2022:4144321. doi: 10.1155/2022/4144321. eCollection 2022.